Presenter: Kevin Pang, Vice President at Lux Research

Kevin is a Vice President, Technology Innovation and Strategy at Lux Research. Kevin is a fanatic about innovation and identifying ways to help Lux’s clients better innovate. To Kevin, innovation is about forcing technology convergence through the asking of new and creative questions. Kevin and the various teams he has led at Lux help our clients find new investable ideas, technologies, partners, markets, and strategies for new growth. Under his leadership, Kevin and his teams built and launched the life science advisory practices at Lux and he most recently served as the global head of Lux’s consulting practice.

Kevin has more than 25 years of industry experience in innovation; first in conducting and leading biotechnology R&D in two companies, one which was acquired and the other IPO, then in pharmaceutical strategic market access intelligence, healthcare IT, and here at Lux, in energy, materials, and life sciences technology strategy innovation. He has served as VP of Product at Decision Resources, a leading pharmaceutical market research and intelligence company helping the world’s top 50 pharma companies optimize therapeutic pipelines using pipeline analysis, market modeling, and forecasting. He co-founded and led an award-winning SaaS-based healthcare medical records data transformation company, and prior to that spent more than 10 years in startup biopharmaceutical discovery research working in neurodegenerative and metabolic diseases.

Kevin received his bachelor’s degrees in Genetics and Molecular Biology from U.C. Berkeley, his Ph.D. from the Department of Physiology and Biophysics from Harvard University, and an MBA in Operations Management from Bentley University.